UCM Stock Overview
Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices worldwide.
Notes are coming soon
Uscom Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.051|
|52 Week High||AU$0.11|
|52 Week Low||AU$0.044|
|1 Month Change||13.33%|
|3 Month Change||2.00%|
|1 Year Change||-51.43%|
|3 Year Change||-83.81%|
|5 Year Change||-78.30%|
|Change since IPO||-97.88%|
Recent News & Updates
|UCM||AU Medical Equipment||AU Market|
Return vs Industry: UCM underperformed the Australian Medical Equipment industry which returned 5.3% over the past year.
Return vs Market: UCM underperformed the Australian Market which returned 2.1% over the past year.
|UCM Average Weekly Movement||n/a|
|Medical Equipment Industry Average Movement||10.0%|
|Market Average Movement||8.5%|
|10% most volatile stocks in AU Market||15.7%|
|10% least volatile stocks in AU Market||3.4%|
Stable Share Price: Insufficient data to determine UCM's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine UCM's volatility change over the past year.
About the Company
Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices worldwide. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function using Doppler ultrasound; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm; and SpiroSonic, a pulmonary function testing device based on multi-path ultrasound technology. The company also provides the SpiroSonic AIR, a digital multipath ultrasonic spirometer with a viral disinfection system for the elimination of COVID and tuberculosis; and respiratory devices.
Uscom Limited Fundamentals Summary
|UCM fundamental statistics|
Is UCM overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|UCM income statement (TTM)|
|Cost of Revenue||AU$344.47k|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.0099|
|Net Profit Margin||-60.62%|
How did UCM perform over the long term?See historical performance and comparison